- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03139786
Follow-up of a Cohort of Patients With Aortic Valve Bicuspidia
February 9, 2023 updated by: Centre Hospitalier Universitaire, Amiens
Prospective Follow-up of a Cohort of Patients With Aortic Valve Bicuspidia: Multicentre Study
The aortic valve bicuspidia (BVA) is a congenital condition corresponding to the presence of 2 sigmoids instead of 3.
This is the most common cardiac congenital anomaly affecting 0.5 to 2% of the population The general rule.
BVA may be associated with structural damage to the ascending aorta, which exposes BVA patients to a risk of developing ascending aortic aneurysm and acute aortic accidents.
Recent data from the literature have revealed that the natural history of BVA is marked by a possible development towards significant valvulopathy and / or an ascending aortic aneurysm often requiring surgical treatment.
However, the natural history of bicuspid disease remains poorly understood and the prognostic factors for progression to severe valvulopathy and / or aneurysmal dilatation of the ascending aorta remain to be determined.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Anticipated)
232
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Picardie
-
Amiens, Picardie, France, 80054
- Recruiting
- CHU Amiens Picardie
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Patients with aortic bicuspidia examined in the echocardiography laboratory at one of the participating centers will be systematically eligible to participate in the study
Description
Inclusion Criteria:
- All patients examined in the echocardiography laboratory whose objective examination was a bicuspid valve of the aortic valve
- Bicuspidia may be formerly known
Exclusion Criteria:
- Refusal to participate
- Patients who had already undergone bicuspid surgery or ascending aorta before being examined at the echocardiography laboratory
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Analysis of 10 year mortality in cardiac surgery in a patient with bicuspid
Time Frame: 10 years
|
Analyzing the natural history of Bicuspidia
|
10 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
October 14, 2011
Primary Completion (ANTICIPATED)
July 1, 2025
Study Completion (ANTICIPATED)
July 1, 2025
Study Registration Dates
First Submitted
April 10, 2017
First Submitted That Met QC Criteria
May 2, 2017
First Posted (ACTUAL)
May 4, 2017
Study Record Updates
Last Update Posted (ACTUAL)
February 10, 2023
Last Update Submitted That Met QC Criteria
February 9, 2023
Last Verified
February 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- PI2012_843_0014
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Aortic Valve, Bicuspid
-
University Hospital AugsburgUniversitätsklinikum Hamburg-Eppendorf; Heart Center Leipzig - University Hospital and other collaboratorsRecruitingAortic Regurgitation Disease | Bicuspid Aortic Valve (BAV)Germany
-
IRCCS San RaffaeleRecruitingBicuspid Aortic Valve (BAV)Italy, Switzerland
-
St. George's Hospital, LondonCompletedThoracic Aortic Aneurysm | Bicuspid Cardiac ValveUnited Kingdom
-
Oregon Health and Science UniversityUniversity of Colorado, Denver; Baylor College of Medicine; University of California... and other collaboratorsCompleted
-
National University of Ireland, Galway, IrelandKarolinska University Hospital; Galway University Hospitals; Kerckhoff Heart... and other collaboratorsEnrolling by invitationAortic Stenosis | Transcatheter Aortic Valve Replacement | Bicuspid Aortic Valve | Transcatheter Aortic Valve ImplantationSweden, Ireland, Germany
-
Boston UniversityNational Heart, Lung, and Blood Institute (NHLBI)Active, not recruitingBicuspid Aortic Valve Disease | Thoracic Aortic Disease in Patients With a Bicuspid Aortic ValveUnited States, Spain, United Kingdom, Italy, Canada
-
Ruijin HospitalRecruiting
-
Institut für Pharmakologie und Präventive MedizinEdwards LifesciencesNot yet recruitingCircle Method Observational Project - Non-interventional, Retrospective, Multicenter Data CollectionAortic Stenosis With Bicuspid ValveUnited Kingdom
-
Shanghai MicroPort CardioFlow Medtech Co., Ltd.The First Affiliated Hospital of Anhui Medical University; West China Hospital and other collaboratorsEnrolling by invitationAortic Stenosis | Bicuspid Aortic Valve (BAV)China
-
Clinique PasteurUnknownBicuspid Aortic ValveFrance
Clinical Trials on Study the natural history of bicuspid
-
Akouos, Inc.Eli Lilly and CompanyRecruitingSensorineural Hearing Loss, BilateralUnited States, Taiwan, Germany, Spain, United Kingdom, Australia, Turkey (Türkiye)
-
InnoskelRecruitingSEDC | Hypochondrogenesis | Semd, Strudwick Type | Kniest DysplasiaFrance, Spain
-
Columbia UniversityNational Eye Institute (NEI); Centre Hospitalier National d'Ophtalmologie des... and other collaboratorsRecruitingRetinitis Pigmentosa | Best Vitelliform Macular DystrophyUnited States, Germany, France
-
Institute of Molecular and Clinical Ophthalmology...Boehringer IngelheimCompletedAge-Related Macular Degeneration | Geographic Atrophy | Visual Field Defect, Central Scotoma of Both EyesSwitzerland
-
University of Milano BicoccaRecruiting
-
University Hospital, BonnGenentech, Inc.CompletedEye Diseases | Age-related Macular Degeneration | Geographic Atrophy | AtrophyGermany
-
Johns Hopkins UniversityNeurofibromatosis Therapeutic Acceleration ProgramActive, not recruitingNeurofibromatosis 1 | Neurofibromatosis Type 1 | Cutaneous Neurofibroma | Neurofibromatosis (Nonmalignant)United States
-
National Cancer Institute (NCI)RecruitingSolid Tumor | Other Solid Tumors | Very Rare Tumors | Very Rare Cancers | Pediatric Rare TumorsUnited States
-
Columbia UniversityLudwig-Maximilians - University of Munich; Moorfields Eye Hospital NHS Foundation... and other collaboratorsSuspendedRetinitis Pigmentosa Associated With CNGB1 MutationsUnited States, United Kingdom, France, Germany
-
University of OxfordHoffmann-La Roche; Foundation for Angelman Syndrome Therapeutics UKRecruiting